N-ornithinyl-35-aminobacteriohopane-32,33,34-triol

(2S)-N-[(2S,3R,4R)-7-[(5aR,5bR,11aS,13bS)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-trihydroxyoctyl]-2,5-diaminopentanamide

OGGRAXQKORUETR-WCDIYWTISA-N CHEBI:183183 0 Reactome links 2 studies

Metabolite details

Identifier: OGGRAXQKORUETR-WCDIYWTISA-N
InChI Key: OGGRAXQKORUETR-WCDIYWTISA-N
IUPAC name: (2S)-N-[(2S,3R,4R)-7-[(5aR,5bR,11aS,13bS)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-trihydroxyoctyl]-2,5-diaminopentanamide
Preferred name: N-ornithinyl-35-aminobacteriohopane-32,33,34-triol
INN name: —
Synonym: —
ChEBI: CHEBI:183183

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months
WT_vs_WT_Aco